Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|4|616-621

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.4, 2015-04, pp. : 616-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose‐level response rates of mtor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 10, 2015-10 ,pp. : 1754-1760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 6, 2015-12 ,pp. : 929-938

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 3, 2015-03 ,pp. : 359-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 618-621

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spinal giant cell tumor in tuberous sclerosis: Case report and review of the literature

By Fraioli Mario Francesco  

Journal of Spinal Cord Medicine, Vol. 36, Iss. 2, 2013-03 ,pp. : 157-160

Maney Publishing

Access to resources Recommend Favorite